J&J to begin trials of single-shot COVID-19 vaccine in India soon
The U.S. drugs and healthcare giant has sent a letter to India s Central Drugs Standard Control Organisation (CDSCO) saying it would very shortly apply for permission to conduct clinical bridging trials in India, according to the report
Reuters | April 9, 2021 | Updated 14:45 IST
Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the Indian Express newspaper reported on Friday.
The U.S. drugs and healthcare giant has sent a letter to India s Central Drugs Standard Control Organisation (CDSCO) saying it would very shortly apply for permission to conduct clinical bridging trials in India, according to the report.
J&J says in talks with Indian government for trial of single-dose vaccine metro.us - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from metro.us Daily Mail and Mail on Sunday newspapers.
India must ensure public trust in Covid vaccine is not eroded thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
3 Min Read
NEW DELHI (Reuters) - Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study.
A vial and sryinge are seen in front of a displayed Pfizer and Biontech logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future. Both countries are running their immunisation campaigns using other products.
EXCLUSIVE-Pfizer withdraws application for emergency use of its COVID-19 vaccine in India reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.